Work

Imatinib Mesylate for Patients (pts) with Hypereosinophilic Syndrome (HES) and Systemic Mastocytosis (SM): A Phase II Trial.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.4752.4752

Authors: Elias Jabbour, Hagop Kantarjian, Srdan Verstovsek, Dan Jones, Susan O’Brien, Raja Luthra, Farhad Ravandi-Kashani, William Wierda, Francis Giles, Mary Beth Rios, Jorge Cortes

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2563198547

FWCI: 0.199

Cites:

Cited by: 1

Related to: 10